KIR Donor Selection: Feasibility in Identifying Better Donors

We previously reported that AML transplants using KIR B haplotype Better or Best (≥2 B activating gene loci ± Cen B/B) unrelated donors (URD) yield less relapse and better survival. In this prospective trial we evaluated 535 AML searches from 14 participating centers with centralized donor KIR genot...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biol Blood Marrow Transplant
Hlavní autoři: Weisdorf, Daniel, Cooley, Sarah, Wang, Tao, Trachtenberg, Elizabeth, Haagenson, Michael D., Vierra-Green, Cynthia, Spellman, Stephen, Spahn, Ashley, Vogel, Jenny, Kobusingye, Hati, Fehninger, Todd, Woolfrey, Ann, Devine, Steven, Ross, Maureen, Waller, Edmund K., Sobecks, Ronald, Parham, Peter, Guethlein, Lisbeth A, GE Marsh, Steven, Miller, Jeffrey
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6310641/
https://ncbi.nlm.nih.gov/pubmed/30149149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.08.022
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky